New pill could tame tough psoriasis – early trial underway
NCT ID NCT07129382
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests an experimental capsule called CS32582 in adults with moderate-to-severe plaque psoriasis. The trial has two parts: a short 4-week dose-finding phase and a longer 12-week phase to see how well the drug clears skin and whether it is safe. About 220 participants will take either the drug or a placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CS32582 capsule
- What this could lead to
- If successful, this could lead to a new oral treatment option for moderate-to-severe plaque psoriasis, helping to clear skin and reduce symptoms.
- What could go wrong
- This is an early phase 1/2 trial with a small number of participants, so safety and effectiveness are not yet proven. The drug may cause side effects or fail to show benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
NOT_YET_RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Affiliated Hospital of Chengde Medical University
NOT_YET_RECRUITINGChengde, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Beijing Friendship Hospital, Capital Medical University
NOT_YET_RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
First Hospital of Shanxi Medical University
NOT_YET_RECRUITINGTaiyuan, Shanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University People's Hospital
NOT_YET_RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shandong Provincial Hospital for Skin Diseases
NOT_YET_RECRUITINGJinan, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shiyan People's Hospital
NOT_YET_RECRUITINGShiyan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affliated Hospital of Wenzhou Medical University
NOT_YET_RECRUITINGWenzhou, Zhengjiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
NOT_YET_RECRUITINGYiwu, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital of Xi'an Jiaotong University(Xibei Hospital )
NOT_YET_RECRUITINGXi’an, Shanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New oral pill TLL018 aims to clear psoriasis plaques in phase 2 trial
- Psoriasis drug may be safe for patients with fatty liver
- New cream shows promise for clearing psoriasis in chinese patients
- Could a simple skincare routine soothe psoriasis Flare-Ups?
- New psoriasis cream shows early promise in small trial
- New biologic drug netakimab tested in kids with psoriasis